Loading
Latest filing published 14 Jan 2019 for MediPharm Labs Corp. (formerly POCML 4 Inc.), €177k.
No signal scores available.
Keith Strachan appears in our data through filings on MediPharm Labs Corp. (formerly POCML 4 Inc.) shares, published by SEDI. The record holds 3 filings, for trades running from 1 October 2018 to 7 January 2019.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 14 January 2019 came the latest disclosure, an option exercise for €177k in MediPharm Labs Corp. (formerly POCML 4 Inc.). The median gap between a trade and its publication by SEDI is 30 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations